Cargando…
Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications
Diabetes mellitus (DM) is a metabolic disease, now prevalent worldwide, which is characterized by a relative or absolute lack of insulin secretion leading to chronically increased blood glucose levels. Diabetic patients are often accompanied by multiple macrovascular complications, such as coronary...
Autores principales: | Xiong, Jiachao, Hu, Hao, Guo, Rong, Wang, Hui, Jiang, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117220/ https://www.ncbi.nlm.nih.gov/pubmed/33995278 http://dx.doi.org/10.3389/fendo.2021.646233 |
Ejemplares similares
-
The roles of mesenchymal stem cell-derived exosomes in diabetes mellitus and its related complications
por: Yang, Mengmeng, et al.
Publicado: (2022) -
Exosomes: Biomarkers and Therapeutic Targets of Diabetic Vascular Complications
por: Chen, Anqi, et al.
Publicado: (2021) -
Mesenchymal Stem Cell-Based Treatment for Microvascular and Secondary Complications of Diabetes Mellitus
por: Davey, Grace C., et al.
Publicado: (2014) -
A bibliometric and visualized research on global trends of immune checkpoint inhibitors related complications in melanoma, 2011–2021
por: Zhang, Hongyi, et al.
Publicado: (2023) -
Emerging Antioxidant Paradigm of Mesenchymal Stem Cell-Derived Exosome Therapy
por: Xia, Chen, et al.
Publicado: (2021)